Search
UT Southwestern study: Cell membrane ‘blebs’ could hold new targets for anti-cancer drugs: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/march-cell-membrane-blebs.html
Cell membrane protrusions called blebs that typically signify the end of life for healthy cells do the opposite for melanoma cells, activating processes in these cells that help them to survive and spread, a UT Southwestern study suggests.
Potential genetic regulators of the heartbeat identified by UT Southwestern researchers : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-genetic-regulators-of-the-heartbeat.html
UT Southwestern Medical Center researchers have mapped gene control elements in specialized cardiac cells responsible for coordinating heartbeats.
UT Southwestern researchers discover gene regulation mechanism: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-gene-regulation-mechanism.html
UT Southwestern Medical Center researchers have discovered a method cells use to turn genes on and off that involves portions of proteins whose function has long been a mystery.
Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-liver-cancer-treatment.html
Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.
UT Southwestern launches SPORE-funded national resource to advance precision medicine for kidney cancer : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/spore-funded-national-resource.html
Funded by a Specialized Program of Research Excellence (SPORE) award from the National Cancer Institute (NCI), the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center reports the largest and most diverse catalog of kidney cancer tumor models to date.
Drug developed by UTSW spinoff approved for metastatic kidney cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-metastatic-kidney-cancer-drug-spinoff.html
The U.S. Food & Drug Administration has expanded the approved use of belzutifan for treatment of metastatic kidney cancer, another milestone for the novel, first-in-class kidney cancer drug arising from scientific discoveries at UT Southwestern Medical Center.
Attacking tumors from the inside: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/attacking-tumors-from-the-inside.html
A new technology that allows researchers to peer inside malignant tumors shows that two experimental drugs can normalize aberrant blood vessels, oxygenation, and other aspects of the tumor microenvironment in non-small cell lung cancer (NSCLC), helping to suppress the tumor’s growth and spread, UT
Cigna Contract Negotiations Update: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/cigna-media-holding-statement.html
Media statement
March of Dimes opens Texas Collaborative Prematurity Research Center: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-march-of-dimes.html
March of Dimes, a national leader in maternal and infant health research, today announced the launch of the Texas Collaborative Prematurity Research Center (PRC), uniting scientists from The University of Texas Medical Branch (UTMB) at Galveston and UT Southwestern Medical Center in Dallas.
Dr. Andrew Ziskind joins Southwestern Health Resources as Senior Executive Officer: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/andrew-ziskind-seo.html
Dr. Andrew Ziskind, a nationally recognized leader of innovative health systems, has been selected as Senior Executive Officer (SEO) for the Southwestern Health Resources Clinically Integrated Network.